Spinal fluid abnormalities in patients with chronic fatigue syndrome

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 1, 2005, Pages 52-55

  Natelson, Benjamin H ^a,b   Weaver, Shelley A ^a   Tseng, Chin Lin ^a   Ottenweller, John E ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 8; PROTEIN;

ADULT; ARTICLE; CELL COUNT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOPATHOLOGY; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; TISSUE LEVEL;

ADULT; AGE FACTORS; CEREBROSPINAL FLUID; COMORBIDITY; CYTOKINES; DEPRESSION; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; PROTEINS;

EID: 12544253722     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.1.52-55.2005     Document Type: Article

References (21)

1. Barsky, A. J., and J. F. Borus. 1999. Functional somatic syndromes. Ann. Intern. Med. 130:910-921.
2. Cook, D. B., G. Lange, J. DeLuca, and B. H. Natelson. 2001. Relationship of brain MRI abnormalities and physical functional status in CFS. Int. J. Neurosci. 107:1-6.
3. DeLuca, J., S. K. Johnson, S. P. Ellis, and B. H. Natelson. 1997. Cognitive functioning is impaired in chronic fatigue syndrome patients devoid of psychiatric disease. J. Neurol. Neurosurg. Psychiatry 62:151-155.
4. DeLuca, J., S. K. Johnson, S. P. Ellis, and B. H. Natelson. 1997. Sudden vs gradual onset of chronic fatigue syndrome differentiates individuals on cognitive and psychiatric measures. J. Psychiatr. Res. 31:83-90.
5. Fukuda, K., S. E. Straus, I. Hickie, M. C. Sharpe, A. Komaroff, A. Schluederberg, J. F. Jones, A. R. Lloyd, S. Wessely, N. G. Gantz, G. P. Holmes, L. Steele, M. Reyes, S. Abbey, J. Rest, H. Jolson, D. L. Peterson, J. H. M. M. Vercoulen, U. Tirelli, B. Evengard, B. H. Natelson, and W. C. Reeves. 1994. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 121:953-959.
6. Gür, A., M. Karakoç, K. Nas, R. Çevik, A. Denli, and J. Saraç. 2002. Cytokines and depression in cases with fibromyalgia. J. Rheumatol. 29:358-361.
7. Hamblin, T. J. 1990. Interleukin 2: side effects are acceptable. BMJ 300: 275-276.
8. Hamilton, J. A. 2002. GM-CSF in inflammation and autoimmunity. Trends Immunol. 23:403-408.
9. Hashimoto, S. I., I. Komuro, M. Yamada, and K. S. Akagawa. 2001. IL-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages. J. Immunol. 167:3619-3625.
10. LaManca, J. J., S. Sisto, J. E. Ottenweller, S. Cook, A. Peckerman, Q. Zhang, T. N. Denny, W. C. Gause, and B. H. Natelson. 1999. Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion. J. Clin. Immunol. 19:135-142.
11. Lange, G., J. DeLuca, J. A. Maldjian, H. J. Lee, L. A. Tiersky, and B. H. Natelson. 1999. Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J. Neurol. Sci. 171:3-7.
12. Lee, E. H., and Y. Rikihisa. 1996. Absence of tumor necrosis factor alpha, interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor expression but presence of IL-1β, IL-8, and IL-10 expression in human monocytes exposed to viable or killed Ehrlichia chaffeensis. Infect. Immun. 64:4211-4219.
13. Lloyd, A., I. Hickie, A. Brockman, J. Dwyer, and D. Wakefield. 1991. Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects. J. Infect. Dis. 164:1023-1024.
14. Lyall, M., M. Peakman, and S. Wessely. 2003. A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J. Psychosom. Res. 55:79-90.
15. Marcus, S., L. N. Robins, and K. Bucholz. 1990. Quick diagnostic interview schedule 3R version 1. Washington University School of Medicine, St. Louis. Mo.
16. Natelson, B. H., M. H. Haghighi, and N. M. Ponzio. 2002. Evidence for the presence of immune dysfunction in chronic fatigue syndrome. Clin. Diagn. Lab. Immunol. 9:747-752.
17. Natelson, B. H., J. J. LaManca, T. N. Denny, A. Vladutiu, J. Oleske, N. Hill, M. T. Bergen, L. Korn, and J. Hay. 1998. Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis. Am. J. Med. 105:43S-49S.
18. Pavol, M. A., C. A. Meyers, J. L. Rexer, A. D. Valentine, P. J. Mattis, and M. Talpaz. 1995. Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology 45:947-950.
19. Pusztai, L., T. R. Mendoza, J. M. Reuben, M. M. Martinez, J. S. Willey, J. Lara, A. Syed, H. A. Pritsche, E. Bruera, D. Booser, V. Valero, B. Arun, N. Ibrahim, E. Rivera, M. Royce, C. S. Cleeland, and G. N. Hortobagyi. 2004. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine 25:94-102.
20. Smets, E. M. A., B. Garssen, B. Bonke, and J. C. J. M. De Haes. 1995. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 39:315-325.
21. Wallace, D. J., M. Linker-Israeli, D. Hallegue, S. Silverman, D. Silver, and M. H. Weisman. 2001. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 40:743-749.